Surgical Oncology: Melanoma


About Us

Melanoma is the most serious and aggressive form of skin cancer. It is a tumor that arises from pigment-forming cells called melanocytes in the skin. Melanoma can invade deeper layers of the skin, and can also spread to nearby lymph nodes and distant parts of the body such as the lung, liver, bone, and brain. Melanoma is highly curable in its early stages. While it can be life threatening, innovative drug therapies are showing significant survival benefit to patients with advanced-stage melanoma.

The Stanford Pigmented Lesion and Melanoma Program offers an integrated, multidisciplinary diagnostic and treatment plan for patients with all stages of melanoma. The program features state-of-the-art expertise from surgical, cutaneous, and medical oncologists, dermatologic and Mohs surgeons, dermatopathologists, cytopathologists, and radiation oncologists. Our clinic offers consultation and treatment for melanoma of from its earliest to most advanced stages, as well as other rare and aggressive skin cancers. Housed in a single location in the 900 Blake Wilbur 3rd floor Cancer Center annex, the Stanford Pigmented Lesion and Melanoma Clinic (PLMC) provides comprehensive, streamlined care for both new and established patients who can be evaluated by multiple specialists at the same visit. Our parallel clinic format enables ongoing tumor board-style discussions between physician specialists, which expedites and optimizes treatment for patients. We strive to provide world-class care by tailoring the latest breakthroughs in melanoma therapy to the specific needs and goals of each individual patient.

The Stanford Pigmented Lesion and Melanoma Clinic is recognized for its:

  • Highly Specialized, Expert Surgical Care. Our surgical group is comprised of highly experienced oncology, head and neck, and plastics/reconstructive surgeons who specialize in wide local excision, complex wound closure, sentinel lymph node biopsy, and lymph node dissection. As a high-volume practice, our surgeons perform over 300 melanoma-related cases annually. In addition, dermatologic and Mohs surgeons contribute to the care of cutaneous melanoma and nonmelanoma skin cancers, performing over 2000 Mohs cases annually for higher risk skin cancers, as well as immunostain-controlled Mohs surgery for certain subtypes of melanoma in situ. Our surgeons are dedicated to achieving the best cancer outcome for each patient, while maximizing overall function and cosmetic appearance.
  • Renowned Dermatologic/Cutaneous Oncology Expertise. Our cutaneous oncologists are dermatologists who have longstanding expertise in prevention, early detection, surveillance, and management of cutaneous and metastatic melanoma. They are esteemed thought leaders in melanoma care and have played an integral role in establishing national evidence-based guidelines for the treatment of melanoma as well as early detection strategies to increase the likelihood of cure. Our Supportive Dermato-Oncology team works to address skin toxicities related to melanoma and other cancer treatment.
  • Breakthrough Treatments for Advanced Melanoma. The discovery of new drugs and therapies for melanoma has revolutionized treatment for advanced melanoma. Our medical oncology group utilizes an array of established and experimental therapies to treat advanced melanoma and other aggressive skin cancers, including immunotherapy, targeted molecular therapy, intratumoral vaccine therapy, and chemotherapy.
  • State-of-the-Art Surveillance Technology. Patients with an atypical mole pattern have a significantly higher risk of developing melanoma. We employ dermoscopy, image capture and total body mole mapping through a new 3-D imaging technology (VetraXT) – located in Stanford Dermatology/Redwood City to assist in the early detection of severely atypical moles and melanoma. Stanford is currently the sole provider of ultra-high resolution 3-D total body mole mapping in the San Francisco Bay Area.
  • Leading-Edge Research and Clinical Trial Recruitment. The discovery of immunotherapy and novel targeted agents has revolutionized the treatment of advanced melanoma. The Stanford Pigmented Lesion and Melanoma Program is at the forefront of these new innovations and offers eligible patients access to multiple cross-institutional and industry-sponsored clinical trials.
     

Cutaneous Oncology Conditions/Skin Cancers We Treat:

  • Melanoma
  • Merkel cell carcinoma
  • Advanced or metastatic squamous cell or basal cell carcinoma
  • Angiosarcoma
  • Apocrine carcinoma
  • Cutaneous leiomyosarcoma
  • Dermatofibrosarcoma protruberans
  • Microcystic adnexal carcinoma
  • Paget's and extramammary Paget's disease
  • Sebaceous carcinoma

 

Melanoma Patient-Care Team

Clinical Assistant Professor, Surgery - General Surgery

Bio

Dr. Lin is a board-certified, fellowship-trained endocrine surgeon whose clinical practice is focused on the surgical management of patients with tumors of the thyroid, parathyroid, and adrenal glands. After receiving her undergraduate degree from Stanford University, Dr. Lin pursued her medical training on the east coast, where she completed her residency in general surgery at Rutgers Robert Wood Johnson Medical School and fellowship in endocrine surgery at the Harvard-affiliated Massachusetts General Hospital. In 2014, Dr. Lin joined the faculty at Stanford School of Medicine and currently serves as Director of the newly established Parathyroid Center at Stanford. Dr. Lin is dedicated to delivering expert, compassionate surgical care that is evidence-based, yet customized to the needs and values of each patient. Her particular areas of clinical expertise are in minimally-invasive parathyroid surgery, treatment of thyroid cancer, and laparoscopic adrenal surgery. Her research focuses on physician wellness and exploring its impact on the physician-patient relationship and clinical outcomes.
Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery Clinical Associate Professor (By courtesy), Orthopaedic Surgery

Bio

Subhro K. Sen, MD, Clinical Associate Professor in the Division of Plastic and Reconstructive Surgery, graduated from Northwestern University with a degree in biomedical engineering. He went on to receive his medical degree from the Northwestern University Feinberg School of Medicine. After medical school, he completed a peripheral nerve research fellowship at the Washington University School of Medicine in St. Louis. He received his postgraduate training in general surgery at Indiana University, followed by plastic and reconstructive surgery at Johns Hopkins University. He completed his training with a hand and upper extremity surgery fellowship at Stanford University. Dr. Sen’s general clinical interests are in reconstructive surgery, microvascular surgery, and hand and upper extremity surgery. His plastic surgery practice includes: post-traumatic extremity reconstruction; post-oncologic reconstruction of the head and neck, trunk and extremities; perforator flap surgery; and melanoma surgery. He is also co-medical director of the Stanford Advanced Wound Care Center. As a hand surgeon in the Robert A. Chase Hand and Upper Limb Center, he has interests in hand trauma, reconstruction, degenerative conditions, peripheral nerve injuries, oncologic conditions and congenital hand differences. In addition to his clinical practice, Dr. Sen is involved in research, publication, and teaching. His peer-reviewed research includes studies on peripheral nerve regeneration, and he has authored a number of book chapters on a variety of hand surgery topics. He has reviewed manuscripts submitted for publication in Plastic and Reconstructive Surgery and Annals of Plastic Surgery. Dr. Sen is double board certified by the American Board of Plastic Surgery and the American Board of Surgery. He is a member of the American Society of Plastic Surgeons, American Society for Reconstructive Microsurgery and the American Society for Surgery of the Hand.
Clinical Assistant Professor, Surgery - General Surgery

Bio

Kimberly Stone, MD is a board certified General Surgeon who specializes in breast surgical oncology and melanoma surgery. She treats all conditions related to breast health including: breast cancer, high risk prevention and screening, benign breast disease, and conditions related to lactation. Dr. Stone completed a breast surgical oncology fellowship at UCSF, where she trained in all aspects of breast surgical oncology, and melanoma surgery. Dr Stone performs all types of breast surgery including total skin and nipple sparing mastectomy, wireless lumpectomy, benign breast disease excisions and axillary surgery. She works closely with plastic and reconstructive surgeons to offer women the best possible cosmetic options and results following treatment. Dr Stone performs melanoma surgery including wide local excision, sentinel lymph node biopsy, and lymph node dissections for melanoma. Dr. Stone strives to deliver compassionate, patient-centered surgical care that is expert and evidence-based while at the same time customized to the unique needs of each patient. She believes that patient empowerment and education are at the heart of an excellent care team.
Edward C. and Amy H. Sewall Professor in the School of Medicine and Professor, by courtesy, of Dermatology

Bio

Dr. Sunwoo was born and raised in St. Louis, Missouri. He received his undergraduate degree from Brown University in Providence, Rhode Island and his medical degree from Washington University in St. Louis, Missouri. He completed his training in Otolaryngology – Head and Neck Surgery at Washington University. Dr. Sunwoo has been at Stanford University since 2008, and his clinical focus is on the surgical management of head and neck cancer, specifically focusing on melanoma and neoplasms of the thyroid and parathyroid glands. He is a member of the Pigmented Lesions and Melanoma Clinic and the Melanoma Working Group at Stanford. He is also the co-founder of the Stanford Thyroid and Parathyroid Tumor Board. In addition to his clinical work, Dr. Sunwoo is the Director of Head and Neck Cancer Research at Stanford University and the principal investigator of an NIH-funded laboratory in the Stanford Cancer Institute. His research is focused on three primary areas: (1) the immune response to cancer, particularly a tumorigenic population of cells within malignancies called cancer stem cells; (2) the biology and developmental programs of a special lymphocyte population involved in innate immunity called natural killer (NK) cells; and (3) intra-tumor and inter-tumor heterogeneity in head and neck cancer.

Clinic Information

Pigmented Lesion and Melanoma Clinic at Blake Wilbur Building
Tel: 650-498-6000

Melanoma Surgery Clinic
Tel: 650-736-0322

Address: 
875 Blake Wilbur Dr.
Palo A lot, CA 94304

 

Loading Map...

Stanford University School of Medicine

875 Blake Wilbur Dr.
Palo Alto CA, 94304
Get Directions

Prepare For Your Appointment

Review the New Patient Packet for information about:

  • What to expect on the day of your appointment
  • Maps, directions, parking, public transit options, and contact information
  • Other patient resources